Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: A mechanism for cognitive dysfunction in HIV-1-associated dementia

Journal of NeuroVirology

Volumn 5, Issue 5, 1999, Pages 519-528

  Xiong, Huangui ^a   Zeng, Yong Chun ^a   Zheng, Jialin ^a   Thylin, Michael ^a   Gendelman, Howard E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Hippocampal slices; HIV 1 associated dementia; Human immunodeficiency virus; Long term potentiation; Monocyte derived macrophages; Neurotoxicity

Indexed keywords

INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; QUINOLINIC ACID;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL CULTURE; CELL FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEARNING; LONG TERM POTENTIATION; MACROPHAGE; MALE; MEMORY; MICROGLIA; MONONUCLEAR PHAGOCYTE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROGENY; RAT; STIMULATION; SUPERNATANT; VIRION;

ADA; ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 0032842354     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909045381     Document Type: Article

References (53)

1. Bashir ZI, Bortolotto ZA, Davies CH, Berretta N, Irving AJ, Seal AJ, Henley JM, Jane DE, Watkins JC, Collingridge GL (1993). Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors. Nature 363: 347 - 350.
2. Bellinger FP, Madamba S, Siggins GR (1993). Interleukin 1β inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628: 227 - 234.
3. Bliss TVP, Lømo T (1973). Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232: 331 - 356.
4. Bliss TVP, Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31 - 39.
5. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Mullins ME, Lipton SA, Gendelman HE (1995). Regulation of nitric oxide synthase activity in human immunodeficiency virus type-1 (HTV-1)-infected monocytes: implications for HTV-associated neurological disease. J Exp Med 181: 735 - 745.
6. Coan EJ, Saywood W, Collingridge GL (1987). MK-801 blocks NMDA receptor-mediated synaptic transmission and long-term potentiation in rat hippocampal slices. Neurosci Lett 80: 111 - 114.
7. Cunningham AJ, Murray CA, O'Neill LAJ, Lynch MA, O'Connor JJ (1996). Interleukin-1β (IL-1β) and tumor necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203: 17 - 20.
8. Dawson VL, Dawson TM, Uhl GR, Snyder SH (1993). Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proc Natl Acad Sci USA 90: 3256 - 3259.
9. Epstein LG, Gendelman HE (1993). Human immunodeficiency virus type 1 infection of the nervous system: pathogeneic mechanisms. Ann Neurol 33: 277 - 287.
10. Everall IP, Luthbert PJ, Lantos PL (1991). Neuronal loss in the frontal cortex in HIV infection. Lancet 337: 1119 - 1121.
11. Gallo P, Frei K, Rordorf C, Lazdins J, Tavolato B, Fontana A (1989). Human immunodeficiency type 1 (HIV-1) infection of central nervous system: an evaluation of cytokines in cerebrospinal fluids. J Neuroimmunol 23: 109 - 116.
12. Gelbard HA, Nottet HSLM, Dzenko KA, Jett M, Genis P, White R, Wang L, Choi YB, Zhang D, Lipton SA, Swindells S, Epstein LG, Gendelman HE (1994). Platelet-activating factor: A candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 68: 4628 - 4635.
13. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997). The neuropathogenesis of HIV-1 dementia. AIDS 97 11: S35 - S45.
14. Gendelman HE, Orenstein J, Martin MA, Ferma C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke D, Skillman D, Meltzer MS (1988). Efficient isolation and propagation of human immunodeficiency virus on recombinant colony stimulating factor 1-treated monocytes. J Exp Med 167: 1428 - 1441.
15. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, Keane RW, Resnick L, Volsky DJ, Epstein LG, Gendelman HE (1992). Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HlV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 176: 1703-1718.
16. Glass JD, Johnson RT (1996). Human immunodeficiency virus and the brain. Ann Rev Neurosci 19: 1 - 26.
17. Glass JD, Fedor H, Wesselingh SL, McArthur JC (1995). Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlation with dementia. Ann Neurol 38: 755 - 762.
18. Haas HS, Schauenstein K (1997). Neuroimmunomodulation via limbic structure - the neuroanatomy of psychoimmunology. Prog Neurobiol 51: 195 - 222.
19. d) macrophages requires the presence of lipid-A-associated proteins. J Immunol 121: 4196 - 4202.
20. Kalter DK, Nakamura M, Turpin JA, Baca LM, Dieffenbach C, Ralph P, Gendelman HE, Meltzer MS (1991). Enhanced HIV replication in MCSF-treated monocytes. J Immunol 146: 298 - 306.
21. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M (1990). Interleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181: 323 - 326.
22. Kauer JA, Malenka RC, Nicoll RA (1988). NMDA application potentiates synaptic transmission in the hippocampus. Nature 334: 250 - 252.
23. Ketzler S, Weis S, Haug H, Budka H (1990). Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropath, Berlin 80: 92 - 94.
24. Kim JP, Choi DW (1987). Quinolinate neurotoxicity in cortical cell culture. Neurosci 25: 423 - 432.
25. Li AJ, Katafuchi T, Oda S, Hori T, Oomura Y (1997). Interleukin-6 inhibits long-term potentiation in rat hippocampal slices. Brain Res 748: 30 - 38.
26. Lipton SA, Gendelman HE (1995). Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 332: 934 - 940.
27. Lynch G, Larson J, Kelso S, Barrionuevo G, Schottler F (1983). Intracellular injection of EGTA block induction of hippocampal long-term potentiation. Nature 305: 719 - 721.
28. Lynch MA (1998). Age-related impairment in long-term potentiation in hippocampus: a role for the cytokine, interleukin-1 beta? Prog Neurobiol 56: 571 - 589.
29. Malenka RC, Kauer JA, Zucker RS, Nicoll RA (1988). Postsynaptic calcium is sufficient for potentiation of hippocampal synaptic transmission. Science 242: 81 - 84.
30. Masliah E, Achim CL, Ge N, DeTheresa R, Terry RD, Wiley CA (1992). Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol 32: 321 - 329.
31. Meucci O, Miller RJ (1996). gp120-induced neurotoxicity in hippocampal pyramidal neuron culture: protective action of TGF-β1. J Neurosci 16: 4080 - 4088.
32. Mehler MF, Rozental R, Dougherty M, Spray DC, Kessler J (1993). Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 362: 62 - 65.
33. Michaels J (1988). Human immunodeficiency virus type 1 (HIV-1) infection of the nervous system: a review. Immunodeficiency Review 1: 71 - 104.
34. Mrak RE, Sheng JG, Griffin WST (1995). Glial cytokines in Alzheimer's disease: review and pathogenic implications. Hum Pathol 26: 816 - 823.
35. Muller WEG, Schroder HC, Ushijima H, Dapper J, Bormann J (1992). gp120 of HIV-1 induces apoptosis in rat cortical cell culture: prevention by memantine. Bur J Pharmacol 226: 209 - 214.
36. Nottet HSLM, Flanagan EM, Flanagan C, Gelbard HA, Gendelman HE, Reinhard Jr JF (1996). The regulation of quinolinic acid in human immunodeficiency virusinfected monocytes. J Neuro Viol 2: 111 - 117.
37. Nottet HSLM, Jett M, Qu-Hui Z, Flanagan C, Rizzino A, Genis P, Baldwin T, Schwartz J, Gendelman HE (1995). A regulatory role for astrocytes in HTV-1 encephalitis: an over-expression of eicosanoids, platelet activating factor and tumor necrosis factor-α by activated virus-infected monocytes is attenuated by primary human astrocytes. J Immunol 154: 3567 - 3581.
38. Oshima KH, Comans TW, Highsmith AK, Ades EW (1995). Removal of human immunodeficiency virus by an 0.04-μm membrane filter. J AIDS Human Retrovirol 8: 64 - 65.
39. Patterson PH, Nawa H (1993). Neuronal differentiation factors/cytokines and synaptic plasiticity. Cell 72: Neuron 10: 123 - 137.
40. Price RW, Sidtis J, Rosenblum M, Scheck AC, Cleary P (1988). The brain and AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239: 586 - 592.
41. Reyes E, Mohar A, Mallory M, Miller A, Masliah E (1994). Hippocampal involvement associated with human immunodeficiency virus encephalitis in Mexico. Arch Pathol Lab Med 118: 1130 - 1134.
42. Rothwell NJ, Hopkins SJ (1995). Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci 18: 130 - 136.
43. Rothwell NJ, Relton JK (1993). Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev. 17: 217 - 227.
44. Spencer DC, Price RW (1992). Human immunodeficiency virus and the central nervous system. Ann Rev Microbiol 46: 655 - 693.
45. Squire LR (1992). Memory and hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99: 195 - 231.
46. Tancredi V, D'Arcangelo G, Grassi F, Tarroni P, Palmieri G, Santoni A, Eusebi F (1992). Tumor necrosis factor alters synaptic transmission in the rat hippocampal slices. Neurosci Lett 146: 176 - 178.
47. Tancredi V, Zona C, Velloti F, Eusebi F, Santoni A (1990). Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus. Brain Res 525: 149 - 151.
48. Wieraszko A, Li G, Kornecki E, Hohan MV, Ehrlich YH (1993). Long-term potentiation in the hippocampus induced by platelet-activating factor. Neuron 10: 553 - 557.
49. Wiley CA, Masliah E, Morey M, Lemere C, DeTheresa R, Grafe M, Hansen L, Terry R (1991). Neocortical damage during HIV infection. Ann Neurol 29: 651 - 657.
50. B receptors in CA1 area of rat hippocampal slices. Brain Res 737: 188 - 194.
51. Xiong H, Zheng J, Thylin M, Gendelman HE (1999). Unraveling the mechanisms for neurotoxicity in HIV-1-associated dementia: Inhibition of neuronal synaptic transmission by macrophage secretory products. AIDS Res Hum Retrov 15: 57 - 63.
52. Zheng J, Gendelman HE (1997). The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 10: 319 - 325.
53. Zheng J, Thylin MR, Persidsky Y, Xiong H, Ghorpade A, Che M, Leisman GB, Cotter R, Gendelman HE (1999). Neuronal destruction in HIV-1-associated dementia: secretory products from HIV-1 infected macrophages affect neuronal function, differentiation, long term potentiation, and viability. J Virol (revised for publication).